Page last updated: 2024-08-21

nandrolone and spironolactone

nandrolone has been researched along with spironolactone in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19903 (30.00)18.7374
1990's1 (10.00)18.2507
2000's3 (30.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haga, N; Ishibashi, M; Itoh, T; Kamata, S; Matsui, T; Nakamura, M; Odaguchi, K; Shimizu, T; Suzuki, T; Yamada, F1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Bolch, OH; Warren, JC1
Jelinek, J; Krajny, M; Selye, H1
Bourgeois, MO; Bray, GA; Greeson, C; Lovejoy, JC; Macchiavelli, R; Partington, C; Rood, JC1
Drapier-Faure, E; Faure, M1
Barretti, D; Da Silva, ND; de Oliveira, EM; Do Carmo, EC; Fernandes, T; Irigoyen, MC; Koike, D; Mattos, KC; Melo, SF; Rosa, KT; Wichi, RB1
da H Silva, A; dos Santos, MC; Ferraz, EF; Marques Neto, SR; Nascimento, JH1
Campos de Carvalho, AC; Ferraz, EB; Marques-Neto, SR; Nascimento, JH; Njaine, B; Rodrigues, DC; Rondinelli, E1

Reviews

1 review(s) available for nandrolone and spironolactone

ArticleYear
[What is the role of hormonal treatments in acne?].
    Annales de dermatologie et de venereologie, 2001, Volume: 128 Supp 1

    Topics: Acne Vulgaris; Androgen Antagonists; Cyproterone; Estrogens; Flutamide; Glucocorticoids; Hormone Antagonists; Humans; Mineralocorticoid Receptor Antagonists; Nandrolone; Patient Selection; Progestins; Spironolactone; Treatment Outcome

2001

Trials

1 trial(s) available for nandrolone and spironolactone

ArticleYear
Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:6

    Topics: Adipose Tissue; Androgen Antagonists; Androgens; Body Composition; Cardiovascular Diseases; Female; Hormones; Humans; Nandrolone; Nandrolone Decanoate; Obesity; Postmenopause; Risk Factors; Spironolactone

1996

Other Studies

8 other study(ies) available for nandrolone and spironolactone

ArticleYear
Aldosterone antagonists. 2. Synthesis and biological activities of 11,12-dehydropregnane derivatives.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:9

    Topics: Adrenalectomy; Animals; Kidney; Male; Mineralocorticoid Receptor Antagonists; Rats; Rats, Inbred Strains; Receptors, Androgen; Receptors, Mineralocorticoid; Receptors, Progesterone; Receptors, Steroid; Structure-Activity Relationship

1987
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Induction of premature menstruation with catatoxic steroids.
    American journal of obstetrics and gynecology, 1971, Dec-15, Volume: 111, Issue:8

    Topics: Abortion, Therapeutic; Adult; Biotransformation; Body Temperature; Contraceptives, Oral; Endometrium; Female; Humans; Menstruation; Nandrolone; Ovulation; Oxymetholone; Phenytoin; Pregnancy; Progesterone; Rape; Spironolactone; Steroids; Stimulation, Chemical; Time Factors

1971
Prevention of digitoxin poisoning by various steroids.
    Journal of pharmaceutical sciences, 1969, Volume: 58, Issue:9

    Topics: Anabolic Agents; Androstanes; Animals; Body Weight; Desoxycorticosterone; Digitoxin; Diuretics; Estradiol; Ethisterone; Ethylestrenol; Female; Fluoxymesterone; Hydrocortisone; Ketones; Methyltestosterone; Nandrolone; Norethandrolone; Norethynodrel; Organ Size; Oxandrolone; Oxymetholone; Poisoning; Pregnanes; Pregnenolone; Progesterone; Pyrazines; Rats; Spironolactone; Testosterone; Triamterene

1969
Anabolic steroid associated to physical training induces deleterious cardiac effects.
    Medicine and science in sports and exercise, 2011, Volume: 43, Issue:10

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Anabolic Agents; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Collagen Type III; Cytochrome P-450 CYP11B2; Heart Ventricles; Losartan; Male; Mineralocorticoid Receptor Antagonists; Nandrolone; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Spironolactone; Stroke Volume; Swimming

2011
The blockade of angiotensin AT1 and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction.
    Acta physiologica (Oxford, England), 2013, Volume: 208, Issue:2

    Topics: Anabolic Agents; Angiotensin II Type 1 Receptor Blockers; Animals; Heart Diseases; Losartan; Male; Mineralocorticoid Receptor Antagonists; Nandrolone; Nandrolone Decanoate; Random Allocation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Spironolactone

2013
AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
    Cardiovascular drugs and therapy, 2014, Volume: 28, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Heart; KATP Channels; Losartan; Male; Mineralocorticoid Receptor Antagonists; Myocardial Reperfusion Injury; Myocardium; Nandrolone; Nandrolone Decanoate; Physical Conditioning, Animal; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptors, Mineralocorticoid; Reperfusion Injury; Spironolactone; Steroids; Ventricular Function, Left

2014
chemdatabank.com